This report contains market size and forecasts of Neuromodulation Devices And Implantable Infusion Pumps in global, including the following market information:
Global Neuromodulation Devices And Implantable Infusion Pumps Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neuromodulation Devices And Implantable Infusion Pumps Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Neuromodulation Devices And Implantable Infusion Pumps companies in 2021 (%)
The global Neuromodulation Devices And Implantable Infusion Pumps market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Spinal Cord Stimulation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuromodulation Devices And Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies and Avery Biomedical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuromodulation Devices And Implantable Infusion Pumps manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuromodulation Devices And Implantable Infusion Pumps Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromodulation Devices And Implantable Infusion Pumps Market Segment Percentages, by Type, 2021 (%)
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Global Neuromodulation Devices And Implantable Infusion Pumps Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromodulation Devices And Implantable Infusion Pumps Market Segment Percentages, by Application, 2021 (%)
Parkinson's disease
Epilepsy
Pain
Other
Global Neuromodulation Devices And Implantable Infusion Pumps Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Neuromodulation Devices And Implantable Infusion Pumps Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuromodulation Devices And Implantable Infusion Pumps revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neuromodulation Devices And Implantable Infusion Pumps revenues share in global market, 2021 (%)
Key companies Neuromodulation Devices And Implantable Infusion Pumps sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Neuromodulation Devices And Implantable Infusion Pumps sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical